Vein Center at Austin Heart Medical Team

Our cardiologists believe that a major role for physicians is to educate patients on their condition, as well as on potential treatment options.

Matthew R Selmon, MD

Interventional Cardiology | Peripheral Vascular Interventions | Venous Disorders

Dr. Selmon specializes in Interventional Cardiology, Peripheral Vascular Intervention, and Venous Disease with a special interest in chronic total occlusions (CTOs). He established Austin Heart’s new Vein Center in 2010 and currently serves as the Medical Director as he continues his work in coronary and peripheral vascular intervention.

Dr. Matthew Selmon is a native Texan who spent 22 years in the San Francisco Bay area as a practicing cardiologist, clinical researcher, and co-founder of Lumend, maker of the Frontrunner and Outback total occlusion devices now sold by J&J Cordis.

Dr. Selmon earned his medical degree at Southwestern Medical School in Dallas, Texas. He went on to complete a cardiology fellowship at University of Missouri in Columbia, Missouri. He then completed a second fellowship in Interventional Cardiology at Sequoia Hospital in Redwood City, California. He is Board Certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology.

While practicing cardiology in California, Dr. Selmon partnered with world renowned cardiologist, Dr. John Simpson, on the coronary and peripheral device development company, Lumend, where he also worked as Chief Medical Officer. After Lumend was acquired in 2005 by J&J Cordis, Dr. Selmon returned to Texas to practice cardiology at Austin Heart, specializing in Interventional Cardiology, Peripheral Vascular Intervention, and Venous Disease with a special interest in chronic total occlusions (CTOs). He established Austin Heart’s new Vein Center in 2010 and currently serves as the Medical Director as he continues his work in coronary and peripheral vascular intervention.

Dr. Selmon served as the national Principal Investigator for the CONNECT II Ocelot Trial, a new OCT directed peripheral chronic total occlusion device, and recently presented the findings at the VIVA Late Breaking Clinical Trials session.

Matthew Selmon

Awards and Special Recognition

Best Austin Doctors 2014

Specialty

Interventional Cardiology, Vein Disease

Office Locations

Heart Hospital, La Grange

News Coverage

Avinger Enrolls First European PAD Patient in CONNECT II Global Clinical Trial—Co-principal investigators for the trial include Arne Schwindt, MD of St. Franziskus Hospital in Muenster, Germany, and Matthew Selmon, MD, Austin Heart

Education

Residency University of Missouri-Columbia School of Medicine, Columbia, MO

Fellowship University of Missouri-Columbia School of Medicine, Columbia, MO

Certifications & Memberships

Cardiovascular Disease, Interventional Cardiology

Gender

Male

Languages Spoken

English

Specialty

Interventional Cardiology

Sub Specialties

Peripheral Vascular Interventions

Venous Disorders

Roger S Gammon, MD

Venous Disorders | Interventional Cardiology | Peripheral Vascular Interventions

Dr. Gammon enjoys being on the cutting edge of research and technology, while applying it in an individualized and personal manner to his patients. Dr. Gammon is Director of Research at Austin Heart. He is triple board certified in Internal Medicine, Cardiology, and Interventional Cardiology.

Dr. Roger Gammon is originally from Drexel, Missouri. He received his Bachelor’s and Medical Degree from the University of Missouri-Kansas City School of Medicine. Dr. Gammon began eight years of postgraduate training with an Internal Medicine residency at Parkland Memorial Hospital in Dallas where he was chosen Chief Resident. This was followed by a fellowship in Interventional Cardiology at Duke University Medical Center.

Dr. Gammon enjoys being on the cutting edge of research and technology, while applying it in an individualized and personal manner to his patients. Dr. Gammon is Director of Research at Austin Heart. In that capacity he has been Principal Investigator on over 100 studies with a particular interest in stem cell studies. Dr. Gammon also enjoys teaching and has given hundreds of invited lectures and published over 50 articles or textbook chapters. He is triple board certified in Internal Medicine, Cardiology, and Interventional Cardiology. He began practice in Austin, Texas in 1992.

Roger Gammon

Awards & Special Recognition

  • Super Doctors® - 2007, 2008, 2010, 2011, 2012, 2013, 2014, 2015, 2016
  • Austin Business Journal Health Care Hero – Stem Cell Research
  • National Research Service Award
  • Eli Lilly Clinical Scholar
  • Who’s Who in Health and Medical Services
  • Visiting Chief Resident, Massachusetts General Hospital, Harvard
  • Visiting Clinical Clerkship, Yale University Medical School

Specialty

Invasive and Interventional Cardiology; Arterial and Venous Intervention

Office Location

Heart Hospital Office (Central Austin)

Personal Interests

Family, travel, hunting, fishing, and outdoors

Professional Associations

  • Travis County Medical Society
  • Texans for Stem Cell Research, Medical Advisory Board
  • Horizons International Peripheral Group
  • Duke University Consortium for Clinical Research

Professional Affiliations

  • Associate Medical Director, Austin Heart, PA (1998-present)
  • Chief of Cardiology, Seton Medical Center (1998-2000)
  • Director of Research, Austin Heart, PA (1994-present)
  • Quality Assurance Committee, Cardiology Division, Seton Medical Center (1994-1997)
  • Director, Cardiac Cath Lab Steering Committee, Seton Medical Center (1994-1997)
  • Board of Directors, American Heart Association, Austin Chapter (1993)
  • Physician Advisory Council, Cardiac Catheterization Lab, Central TX Heart Institute (1993)
  • Presenter, American Heart Association National Convention (1990)
  • Presenter, American College of Cardiology National Convention (1990)
  • Clinical Competence Committee, Parkland Memorial Hospital (1987-1988)
  • Quality Assurance Committee, Parkland Memorial Hospital (1987-1988)
  • Medical Advisory Committee, Parkland Memorial Hospital (1987-1988)
  • Quality Assurance Committee, Dallas Veterans Administration Hospital (1987-1988)
  • Pharmacy and Therapeutics Committee, Dallas Veterans Administrations Hospital (1987-1988)
  • Instructor in Physical Examination and Diagnosis, Duke University Physician Assistant Program (1987-1988)
  • Instructor in Physical Examination and Diagnosis, University of Texas Southwestern Physician Assistant Program (1985)
  • Clerkship, Cardiology, University of Texas Health Science Center (1983)
  • University Scholar, University of Missouri, Kansas City, Missouri (1979-1981)
  • Curator Scholar, University of Missouri-Kansas City (1978)
  • Valedictorian, Drexel High School, Resolution of Recognition Outstanding Achievement, Missouri Senate (1978)

Publications

  • Reisz GR, Gammon RS. Toxic pneumonitis from mixing household cleaners. CHEST 1986;89:49-52.
  • McBride W, Jackman JD Jr, Gammon RS, Willerson JT. High-output cardiac failure in patients with multiple myeloma. N Engl J Med 1988;319:1651-1653.
  • Chapman GD, Gammon RS, Bauman RP, Howell S, Clark H, Mikat E, Palmos L, Buller CE, Stack RS. A bioabsorbable stent: Initial experimental results. Circulation 1990;82(Suppl III):III-72.
  • Gammon RS, Chapman GD, Bauman RP, Muhlstein JB, Overman AB, Desper JS, MacGregor DC, DeCoriolis PE, Stack RS. The Cordis balloon-expandable stent: Implantation features and long-term follow-up in an animal model. Circulation 1990:82(suppl II):III-541.
  • Chapman GD, Gammon RS, Bauman RP, Stack RS. Intravascular stents: A review. Trends in Cardiovascular Medicine 1991;1:127-131.
  • Gammon RS, Chapman GD, Agrawal GM, Bauman RP, Philips HR, Clark HG, Stack RS. Mechanical features of the Duke biodegradable stent. J Am Coll Cardiol 1991;17:235A.
  • Chapman GD, Lim CS, Swain JL, Gammon RS, Bauman RP, Stack RS. In viro cardiovascular gene transfer via interventional technique: Initial experimental results. J Am Coll Cardiol 1991;1725:A.
  • Gammon RS, Chapman GD, Bauman RP, Stack RS. Bioabsorbable endovascular stent prostheses. In Sigwart U (ed.), Cardiac Stenting, Springer-Verlag, New York.
  • Chapman GD, Lim CS, Gammon RS, Culp SC, Desper JS, Bauman RP, Swain JL, Stack RS. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circulation Research.
  • Gammon RS, Sketch MH Jr, Stack RS. Transluminal Extraction Endarterectomy. In Serruys PW, Strauss BH, King III SB (ed.) Restenosis: After Intervention with new mechanical devices. Kluwer Academic Publishers, Boston, MA pp.259-272, 1992.
  • Zidar JP, Gammon RS, Chapman GD, Culp SC, Brott BC, Clark H, Bauman RP, Waller BF, Phillip HR, Stack RS. Short and long-term vascular tissue response to the Duke bioabsorbable stent. J Am Coll Cardiol, 1993.
  • Zidar JP, Virmani R, Culp SC, Bauman RP, Wells HA, Gammon RS, Chapman GD, Jackman JD, Phillips HR, Stack RS. Quantitative histopathologic analysis of the vascular response to heparin coating of the Cordis stent. J Am Coll Cardiol, 1993.
  • Kruse KR, Greenberg CS, Tangusay JF, Gammon RS, Muhlstein JB, Krucoff MW, Matar FA, Morrison LA, Sawchak SR, Berkowitz SD, Philips HR, Stack RS, Califf RM, Zidar JP. Thrombin and fibrin activity in patients treated with Enoxaparin, Ticlopidine and aspirin versus the conventional Coumadin regimen after elective stenting: The ENTICES Trial. J Am Coll Cardiol, 1996; Vol 27, No. 2:p.334A.
  • Goolsby JP, Gammon RS, Pederson RW, et al. Coronary Stenting: The Austin Heart Experience. Travis County Medical Society Journal, May/June 1997.
  • Gammon, RS,. Ducote, V., Kalmaz, D., Hagan, K., Cheema, A., and Rodgers, G. Impact of Ticlopidine on Bleeding Events During Coronary Artery Bypass (CAB). The American Journal of Cardiology, TCT Abstracts, October 1998.
  • Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado, Metzger C, Brodman M, Pilger E, Zeller T, Krishnan P, Gammon R for the LEVANT 2 Investigators. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. New England Journal of Medicine 2015; 373: 145-153.

Education

Medical School University of Missouri-Kansas City School of Medicine, Kansas City, MO

Residency Parkland Medical Center, Dallas, TX

Fellowship Duke University Medical Center, Durham, NC

Certifications & Memberships

Internal Medicine, Cardiovascular Disease, Interventional Cardiology

Gender

Male

Languages Spoken

English

Specialties

Venous Disorders
Interventional Cardiology

Sub Specialty

Peripheral Vascular Interventions

Jay Pandya, MD

Interventional Cardiology | Peripheral Vascular Interventions | Venous Disorders

Dr. Pandya specializes in advanced coronary and peripheral vascular/arterial interventions. He also provides complex percutaneous therapy for advanced venous conditions, including treatment for DVTs (blood clots in the arms/legs), pulmonary embolisms (blood clots in the lung), venous ulcers, and varicose veins. Dr. Pandya educates his patients on their condition, as well as on potential treatment options.

Born and raised in the Chicago area, Dr. Jay Pandya earned his medical degree from Rush Medical College, and went on to complete a cardiology fellowship at Northwestern University in Chicago. He then completed a second fellowship in interventional cardiology at the University of Illinois, where he was trained in advanced coronary and peripheral vascular/arterial interventions. At that time he was mentored in advanced radial artery catheterization techniques, and now performs the vast majority of his heart procedures through the wrist, as well as many of his peripheral vascular procedures.

In addition to being a specialist in minimally invasive peripheral arterial interventions, Dr Pandya also provides complex percutaneous therapy for advanced venous conditions, including treatment for DVTs (blood clots in the arms/legs), pulmonary embolisms (blood clots in the lung), venous ulcers, and varicose veins.

Dr. Pandya believes a major role for physicians is to educate patients on their condition, as well as on potential treatment options. In his spare time, he enjoys being with his family, traveling, hiking, music, and mountain biking.

Office Locations

Harker Heights, Round Rock, Temple

Jay Pandya

Media Features

Publications

  • PANDYA SB, Kim YH, Meyers SN, Davidson CJ, Flaherty JD, Park DW, Mediratta A, Pieper K, Reyes E, Bonow RO, Park SJ, Beohar N. Drug-Eluting Stents versus Bare Metal Stents in Unprotected Left Main Coronary Artery Stenosis: a Meta-Analysis, Journal of the American College of Cardiology: Cardiovascular Interventions, June 2010; Vol 3 No 6: 602-611
  • Beohar N, Rapp J, PANDYA SB, Losordo DW. Rebuilding the Damaged Heart: The Role of Cytokines and Growth Factors in the Treatment of Ischemic Heart Disease, Journal of the American College of Cardiology, October 2010; Vol 56, No 16: 1287-1297
  • Rajamannan NM, Nealis TB, Subramanian M, PANDYA SB, Stock S, Ignatiev CI, Sebo TJ, Rosengart T, Edwards WD, McCarthy PM, Bonow RO, Spelsberg TC. Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone Formation, Circulation 2005; 111: 3296 - 3301
  • Rajaram V, PANDYA SB, Patel S, Meyer PM, Goldin M, Feinstein MJ, Neems R, Liebson PR, Fiedler BM, Macioch JE, Feinstein SB. Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy, American Journal of Cardiology 2004; 93(11A): 32C-48C
  • Patel SN, Rajaram V, PANDYA SB, Fiedler BM, Bai CJ, Neems R, Feinstein M, Goldin M, Feinstein SB. Emerging, Noninvasive Surrogate Markers of Atherosclerosis, Current Atherosclerosis Reports 2004; 6(1): 60-8

Abstracts

  • Rajamannan NM, Gallagher PS, Le TA, PANDYA SB, MConnel J, Singh R, Gocek J, Caira F, Subramaniam M, Spelsberg TC. Atorvastatin Attenuates Vascular Glomeruli Atherosclerosis in Experimental Hypercholesterolemia., Journal of the American College of Cardiology. 2005; 45(3) Supplement 1:A367

Presentations

  • PANDYA SB, Subramanian M, Stock S, Spelsberg TC, McCarthy P, Bonow RO, Rajamannan NM. Degenerative Versus Rheumatic Mitral Valve Disease: A Comparison of Cellular Proliferation and Osteoblast Mediated Extracellular Matrix Production, American College of Cardiology Scientific Session Orlando, FL March 2005
  • PANDYA SB, Subramanian M, Stock S, Spelsberg TC, McCarthy P, Bonow RO, Rajamannan NM. Human Mitral Valve Degeneration is Associated with an Osteoblast Phenotype, Central Society for Clinical Research / Midwestern Section American Federation for Medical Research Chicago IL March, 2005

Education

Medical School Rush Medical College, Chicago, Illinois

Residency Internal Medicine, McGaw Medical Center of Northwestern University, Northwestern Memorial Hospital/VA Chicago, Chicago, Illinois

Fellowship Cardiovascular Disease, McGaw Medical Center of Northwestern University, Northwestern Memorial Hospital/VA Chicago, Chicago, Illinois
Interventional Cardiology Fellowship: UIC-Christ Advocate Medical Center, Chicago, Illinois

Certifications & Memberships

Interventional Cardiology

Gender

Male

Languages Spoken

English

Specialty

Interventional Cardiology

Sub Specialties

Peripheral Vascular Interventions
Venous Disorders

Mark F Picone, DO

Interventional Cardiology | Peripheral Vascular Interventions | Venous Disorders

Dr. Mark Picone comes to Austin from Rochester, New York and did his cardiology fellowship at the University of Wisconsin Hospital in Madison, Wisconsin. He is American Board of Internal Medicine certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology.

Dr. Mark Picone comes to Austin from Rochester, New York. After completing his undergraduate degree at the State University of New York in Brockport, New York, he received his medical degree from New York College of Osteopathic Medicine in Old Westbury, New York. Post-graduate training began with an Internal Medicine residency at St. Joseph Mercy Hospital in Ann Arbor, Michigan, followed by a cardiology fellowship at the University of Wisconsin Hospital in Madison, Wisconsin. He is American Board of Internal Medicine certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology.

Mark Picone

Specialty

Coronary and Vascular Intervention

Office Locations

Heart Hospital Office (Central Austin), Marble Falls

Personal Interests

Family, tennis, running, travel

Professional Associations

  • American College of Cardiology
  • Society of Coronary Angiography and Intervention
  • American Osteopathic Association
  • Travis County Medical Society
  • Texas Medical Association
  • American Heart Association

Professional Affiliations

  • Vice Chair, Executive Committee/Board of Directors, Austin Heart
  • Chairman, Pharmacy and Therapeutics Committee, Heart Hospital of Austin

Education

Medical School New York College of Osteopathic Medicine, Old Westbury, New York

Residency St. Joseph Mercy Hospital, Ann Arbor, MI

Rellowship University of Wisconsin Hospital, Madison, WI

Certifications & Memberships

Internal Medicine, Cardiovascular Disease, Interventional Cardiology

Gender

Male

Languages Spoken

English

Specialty

Interventional Cardiology

Sub Specialties

Peripheral Vascular Interventions
Venous Disorders


"The entire staff at the Vein Center was excellent/outstanding!!!! Every single person I encountered. I'm a recently retired RN… not used to being on this side of the fence. It makes me feel more confident/secure as I age. Great people/great dedicated professionals!" - Joyce S.



Locations

Retrieving location data...